Patel Sanjiv files Form 144 for RLAY
- Filer CIK: 0001816210
- Shares to sell: 96401
- Date of sale: 10/07/2026
Sanjiv Patel, reporting
RLAY
Relay Therapeutics, Inc. SEC filings
Every EDGAR filing for Relay Therapeutics, Inc. (RLAY), newest first, with AI summaries and stories.
- Ticker
- RLAY
- CIK
- 1812364
- Latest filing
- Oct 8
Next: earnings expected ~Nov 6 · 10-Q expected ~Nov 6 (deadline Nov 9)
Insider activity
No open-market insider buys in the last 30 days.
Also: 3 open-market sales ($1.2M).
Filings
Every filing, newest first. MAJOR and NOTABLE filings lead the app's feed; ROUTINE ones are kept here.
ROUTINE144Relay Therapeutics, Inc.RLAYLIVE ROUTINE4Relay Therapeutics, Inc.RLAYLIVE 2 insider filings
Sanjiv Patel, insider filing for RLAY
Show all 2
- 4Insider filing for RLAY
- 4Insider filing for RLAY
Sanjiv Patel, reporting
ROUTINE144Relay Therapeutics, Inc.RLAYLIVE Relay Therapeutics: Catinazzo files Form 144
- Filer: Thomas Catinazzo
- Shares to sell: 93,153
- Date of sale: 10/06/2026
Thomas Catinazzo, reporting
ROUTINE4Relay Therapeutics, Inc.RLAYLIVE 3 insider filings
Donald A Bergstrom, insider filing for RLAY
Show all 3
- 4Insider filing for RLAY
- 4Insider filing for RLAY
- 4Insider filing for RLAY
Donald A Bergstrom, reporting
ROUTINE4Relay Therapeutics, Inc.RLAYLIVE Peter Rahmer, insider filing for RLAY
Peter Rahmer, reporting
ROUTINE4Relay Therapeutics, Inc.RLAYLIVE SB INVESTMENT ADVISERS (UK) LTD, insider filing for RLAY
SB INVESTMENT ADVISERS (UK) LTD, reporting · SOFTBANK VISION FUND (AIV M2) L.P., reporting · +1 more
ROUTINE144Relay Therapeutics, Inc.RLAYLIVE Peter Rahmer, planned sale of RLAY shares
Peter Rahmer, reporting
ROUTINE144Relay Therapeutics, Inc.RLAYLIVE SVF Pauling (Cayman) Ltd, planned sale of RLAY shares
SVF Pauling (Cayman) Ltd, reporting
ROUTINE4Relay Therapeutics, Inc.RLAYLIVE 2 insider filings
Thomas Catinazzo, insider filing for RLAY
Show all 2
- 4Insider filing for RLAY
- 4Insider filing for RLAY
Thomas Catinazzo, reporting
ROUTINESCHEDULE 13G/ARelay Therapeutics, Inc.RLAYLIVE Ownership stake disclosure by Commodore Capital LP (amended)
Commodore Capital LP, filed by
ROUTINESCHEDULE 13G/ARelay Therapeutics, Inc.RLAYLIVE Ownership stake disclosure by PERCEPTIVE ADVISORS LLC (amended)
PERCEPTIVE ADVISORS LLC, filed by
ROUTINESCHEDULE 13G/ARelay Therapeutics, Inc.RLAYLIVE Ownership stake disclosure by FMR LLC (amended)
FMR LLC, filed by
ROUTINE424B5Relay Therapeutics, Inc.RLAYLIVE NOTABLE10-QRelay Therapeutics, Inc.RLAYLIVE ROUTINE8-KRelay Therapeutics, Inc.RLAYLIVE ROUTINESCHEDULE 13GRelay Therapeutics, Inc.RLAYLIVE Ownership stake disclosure by FMR LLC
FMR LLC, filed by
ROUTINE144Relay Therapeutics, Inc.RLAYLIVE Sekar Kathiresan, planned sale of RLAY shares
Sekar Kathiresan, reporting
ROUTINE144Relay Therapeutics, Inc.RLAYLIVE Sekar Kathiresan, planned sale of RLAY shares
Sekar Kathiresan, reporting
ROUTINE4Relay Therapeutics, Inc.RLAYLIVE 3 insider filings
Peter Rahmer, insider filing for RLAY
Show all 3
- 4Insider filing for RLAY
- 4Insider filing for RLAY
- 4Insider filing for RLAY
Peter Rahmer, reporting
ROUTINE144Relay Therapeutics, Inc.RLAYLIVE Sekar Kathiresan, planned sale of RLAY shares
Sekar Kathiresan, reporting
ROUTINE144Relay Therapeutics, Inc.RLAYLIVE Sekar Kathiresan, planned sale of RLAY shares
Sekar Kathiresan, reporting
ROUTINE4Relay Therapeutics, Inc.RLAYLIVE 3 insider filings
Donald A Bergstrom, insider filing for RLAY
Show all 3
- 4Insider filing for RLAY
- 4Insider filing for RLAY
- 4Insider filing for RLAY
Donald A Bergstrom, reporting
ROUTINE144Relay Therapeutics, Inc.RLAYLIVE Sanjiv Patel, planned sale of RLAY shares
Sanjiv Patel, reporting
ROUTINE4Relay Therapeutics, Inc.RLAYLIVE Peter Rahmer, insider filing for RLAY
Peter Rahmer, reporting
ROUTINE144Relay Therapeutics, Inc.RLAYLIVE Peter Rahmer, planned sale of RLAY shares
Peter Rahmer, reporting
ROUTINE4Relay Therapeutics, Inc.RLAYLIVE 2 insider filings
Thomas Catinazzo, insider filing for RLAY
Show all 2
- 4Insider filing for RLAY
- 4Insider filing for RLAY
Thomas Catinazzo, reporting
ROUTINE144Relay Therapeutics, Inc.RLAYLIVE 2 Form 144 notices
Donald A Bergstrom, planned sale of RLAY shares
Show all 2
- 144Planned insider sale of RLAY shares
- 144Planned insider sale of RLAY shares
Donald A Bergstrom, reporting
ROUTINE4Relay Therapeutics, Inc.RLAYLIVE 7 insider filings
Mark Murcko, insider filing for RLAY
Show all 7
- 4Insider filing for RLAY
- 4Insider filing for RLAY
- 4Insider filing for RLAY
- 4Insider filing for RLAY
- 4Insider filing for RLAY
- 4Insider filing for RLAY
- 4Insider filing for RLAY
Mark Murcko, reporting
ROUTINE8-KRelay Therapeutics, Inc.RLAYLIVE ROUTINE8-KRelay Therapeutics, Inc.RLAYLIVE ROUTINE424B5Relay Therapeutics, Inc.RLAYLIVE ROUTINE424B5Relay Therapeutics, Inc.RLAYLIVE ROUTINE8-KRelay Therapeutics, Inc.RLAYLIVE ROUTINESCHEDULE 13G/ARelay Therapeutics, Inc.RLAYLIVE Ownership stake disclosure by Point72 Asset Management, L.P. (amended)
Point72 Asset Management, L.P., filed by